Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera.
a Division of Hematology/Medical Oncology, Myeloproliferative Neoplasm Center , Weill Cornell Medicine , New York , NY , USA.
Richard T
RT
Silver
a Division of Hematology/Medical Oncology, Myeloproliferative Neoplasm Center , Weill Cornell Medicine , New York , NY , USA.
Spencer
S
Krichevsky
a Division of Hematology/Medical Oncology, Myeloproliferative Neoplasm Center , Weill Cornell Medicine , New York , NY , USA.
Stefani
S
Gjoni
b Wessex Regional Genetics Laboratory , Salisbury District Hospital , Salisbury , UK.
Nicholas C P
NCP
Cross
D000328:Adult; D000368:Aged; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000097:blood* / Q000175:diagnosis* / Q000235:genetics
D004921:Erythropoietin; C507924:JAK2 protein, human; D053614:Janus Kinase 2